Listed

Cryo Cell International Inc: Form 10-Q for the period ended Aug 31, 2018

Filed with the SEC on Oct 15, 2018 and accepted by EDGAR at Oct 15, 2018, 21:02 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-08-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2018-06-01 to 2018-08-31$7.9mus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Revenue9 months2017-12-01 to 2018-08-31$20.6mus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Cost of revenue3 months2018-06-01 to 2018-08-31$2.5mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2017-12-01 to 2018-08-31$5.9mus-gaap:CostOfGoodsAndServicesSold
Research and development3 months2018-06-01 to 2018-08-31$22.2kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2017-12-01 to 2018-08-31$64.9kus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2018-06-01 to 2018-08-31$4.4mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2017-12-01 to 2018-08-31$11.5mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2018-06-01 to 2018-08-31$920.1kus-gaap:OperatingIncomeLoss
Operating income9 months2017-12-01 to 2018-08-31$3.1mus-gaap:OperatingIncomeLoss
Interest expense3 months2018-06-01 to 2018-08-31$410.4kus-gaap:InterestExpense
Interest expense9 months2017-12-01 to 2018-08-31$995.4kus-gaap:InterestExpense
Income tax3 months2018-06-01 to 2018-08-31$303.1kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2017-12-01 to 2018-08-31$3.8mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2018-06-01 to 2018-08-31$245.0kus-gaap:NetIncomeLoss
Net income9 months2017-12-01 to 2018-08-31−$1.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2018-06-01 to 2018-08-31$0.03us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2017-12-01 to 2018-08-31−$0.24us-gaap:EarningsPerShareDiluted
Basic EPS3 months2018-06-01 to 2018-08-31$0.03us-gaap:EarningsPerShareBasic
Basic EPS9 months2017-12-01 to 2018-08-31−$0.24us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2018-06-01 to 2018-08-318,375,675 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2017-12-01 to 2018-08-317,350,868 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2017-12-01 to 2018-08-31$4.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2017-12-01 to 2018-08-31$408.3kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2018-08-31$7.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2018-08-31$30.5mus-gaap:AssetsCurrent
Total assetsAt period end2018-08-31$42.7mus-gaap:Assets
Current liabilitiesAt period end2018-08-31$14.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2018-08-31$52.5mus-gaap:Liabilities
Long-term debtAt period end2018-08-31$1.4mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2018-08-31−$9.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-18-299303. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.